AR128245A1 - Nuevos derivados de ácido hialurónico como rellenos innovadores - Google Patents
Nuevos derivados de ácido hialurónico como rellenos innovadoresInfo
- Publication number
- AR128245A1 AR128245A1 ARP230100063A ARP230100063A AR128245A1 AR 128245 A1 AR128245 A1 AR 128245A1 AR P230100063 A ARP230100063 A AR P230100063A AR P230100063 A ARP230100063 A AR P230100063A AR 128245 A1 AR128245 A1 AR 128245A1
- Authority
- AR
- Argentina
- Prior art keywords
- acid derivatives
- hyaluronic acid
- fillers
- new
- innovative
- Prior art date
Links
- 239000000945 filler Substances 0.000 title abstract 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical class CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 3
- 230000000975 bioactive effect Effects 0.000 abstract 2
- 230000002500 effect on skin Effects 0.000 abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 238000004132 cross linking Methods 0.000 abstract 1
- 230000007515 enzymatic degradation Effects 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 210000004872 soft tissue Anatomy 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Biotechnology (AREA)
- Dispersion Chemistry (AREA)
- Genetics & Genomics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Materials Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a nuevos derivados de ácido hialurónico conjugados con moléculas de origen natural dotadas de propiedades antiinflamatorias y/o antioxidantes y procesos para su fabricación. La unión covalente de estas moléculas bioactivas a los ácidos hialurónicos y el grado de reticulación con estos proporcionan características peculiares en términos de la liberación controlada de las moléculas bioactivas y de propiedades viscoelásticas, y estabilizan los derivados hialurónicos obtenidos contra la degradación química y enzimática. Estos nuevos derivados de ácido hialurónico son útiles para la preparación de composiciones de relleno dérmico inyectables eficaces como rellenos de tejidos blandos, como rellenos dérmicos y subdérmicos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202263298224P | 2022-01-11 | 2022-01-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR128245A1 true AR128245A1 (es) | 2024-04-10 |
Family
ID=85036991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP230100063A AR128245A1 (es) | 2022-01-11 | 2023-01-10 | Nuevos derivados de ácido hialurónico como rellenos innovadores |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR128245A1 (es) |
AU (1) | AU2023206591A1 (es) |
TW (1) | TW202333793A (es) |
WO (1) | WO2023135135A1 (es) |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1219587B (it) | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | Polisaccaridi carbossiilici autoreticolati |
IT1317358B1 (it) | 2000-08-31 | 2003-06-16 | Fidia Advanced Biopolymers Srl | Derivati cross-linkati dell'acido ialuronico. |
FR2861734B1 (fr) * | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
US20050142152A1 (en) | 2003-12-30 | 2005-06-30 | Leshchiner Adelya K. | Polymeric materials, their preparation and use |
US20050226936A1 (en) | 2004-04-08 | 2005-10-13 | Q-Med Ab | Method of soft tissue augmentation |
DE102006013594A1 (de) | 2006-03-22 | 2007-09-27 | Biopolymer Gmbh & Co. Kg | Quervernetzte Gele von Hyaluronsäure und deren Verwendung |
US8318695B2 (en) | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
PT2637710T (pt) | 2010-11-08 | 2017-07-12 | Allergan Ind Sas | Formulações à base de ácido hialurónico |
CA2844785A1 (en) | 2011-08-25 | 2013-02-28 | Allergan, Inc. | Dermal filler compositions including antioxidants |
CA2848833C (en) | 2011-09-14 | 2017-04-04 | Gabriel N. NJIKANG | Ascorbate modified crosslinked hyaluronic acid dermal filler compositions that exhibit reduced tyndall effect |
EP2861626B1 (en) | 2012-06-15 | 2018-12-19 | Merz Pharma GmbH & Co. KGaA | Method of preparing a composition based on hyaluronic acid |
FR2997014B1 (fr) | 2012-10-24 | 2015-03-20 | Teoxane | Composition sterile dermo-injectable |
KR20160031081A (ko) | 2014-09-11 | 2016-03-22 | 중앙대학교 산학협력단 | 수용성 다당류 및 항산화제를 포함하는 복합체 |
US10722444B2 (en) | 2014-09-30 | 2020-07-28 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
TWI716365B (zh) | 2014-11-13 | 2021-01-21 | 德商梅茲製藥有限兩合公司 | 注射型真皮填充劑組合物及其套組、製備方法、與使用 |
ES2872551T3 (es) | 2015-06-30 | 2021-11-02 | Merz Pharma Gmbh & Co Kgaa | Método para la producción de ácido hialurónico reticulado |
ES2836473T3 (es) | 2015-06-30 | 2021-06-25 | Merz Pharma Gmbh & Co Kgaa | Método de preparación de una composición basada en ácido hialurónico |
US11021580B2 (en) | 2015-07-27 | 2021-06-01 | Galderma Holding SA | Process for efficient cross-linking of hyaluronic acid |
EP3162813A1 (en) | 2015-11-02 | 2017-05-03 | Merz Pharma GmbH & Co. KGaA | Process for depleting epoxide species in crosslinked poly-saccharide gel compositions and compositions obtained thereby |
TWI727014B (zh) | 2016-03-24 | 2021-05-11 | 德商梅茲製藥有限兩合公司 | 修飾透明質酸與其製造方法及其用途 |
KR20180010361A (ko) | 2016-07-20 | 2018-01-31 | 중앙대학교 산학협력단 | 히알루론산 하이드로 겔 및 이의 제조 방법 |
WO2018024795A1 (en) | 2016-08-03 | 2018-02-08 | Galderma Research & Development | Method of crosslinking glycosaminoglycans |
WO2018083195A1 (en) | 2016-11-03 | 2018-05-11 | Merz Pharma Gmbh & Co. Kgaa | Method for preparing hyaluronic acid dermal fillers, dermal fillers obtained thereby and their use |
EP3538066B1 (en) | 2016-11-11 | 2021-12-29 | Anteis SA | Hyaluronic acid dermal fillers crosslinked with citric acid, method for making same and uses thereof |
CN106674362A (zh) * | 2016-11-21 | 2017-05-17 | 华南理工大学 | 用乙醇溶剂制备对苯二甲酰氯交联淀粉的方法 |
US20200046627A1 (en) * | 2017-03-24 | 2020-02-13 | Teo ALBARANO | Pharmaceutical compositions |
-
2023
- 2023-01-10 WO PCT/EP2023/050456 patent/WO2023135135A1/en active Application Filing
- 2023-01-10 AU AU2023206591A patent/AU2023206591A1/en active Pending
- 2023-01-10 TW TW112100951A patent/TW202333793A/zh unknown
- 2023-01-10 AR ARP230100063A patent/AR128245A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2023206591A1 (en) | 2024-08-22 |
TW202333793A (zh) | 2023-09-01 |
WO2023135135A1 (en) | 2023-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1124783T1 (el) | Συνθεσεις για in situ ενεσιμα βιοαποδομησιμα εμφυτευματα | |
AR107967A1 (es) | Ácido hialurónico modificado, método para su preparación y usos del mismo | |
EA200971116A1 (ru) | Способ желатинизации фиброина шелка с применением обработки ультразвуком | |
BR112018004536A2 (pt) | peptídeos de endereçamento à cartilagem | |
UY31198A1 (es) | Amidas de ácidos benzoicos triazinil sustituidos, composiciones farmacéticas conteniéndolos y aplicaciones. | |
BR9915235A (pt) | ácidos hialurÈnicos reticulados e usos médicos dos mesmos | |
WO2010057142A3 (en) | Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti adhesion barriers and anti thrombotic materials | |
ECSP10010352A (es) | Gel de quitosano para aplicaciones dermatologicas, proceso de obtencion y uso del mismo | |
CY1124718T1 (el) | Ανθεκτικο στη διασπαση υαλουρονικο χαμηλου μοριακου βαρους με σταυροδεσμους | |
PE20091007A1 (es) | Depsipeptidos ciclicos como moduladores de calicreina 7 | |
BR112019004332A2 (pt) | géis injetáveis que compreendem ácido hialurônico reticulado e hidroxiapatita, composição e processo de fabricação dos mesmos | |
CY1114716T1 (el) | Ανασυσταθεντα επιφανειοδραστικα τα οποια διαθετουν βελτιωμενες ιδιοτητες | |
AR077372A1 (es) | Composiciones y metodos para tratar infecciones oftalmicas oticas o nasales | |
BR112014021653A2 (pt) | Formulação tópica, método para tratamento de feridas e método para fabricar uma formulação tópica | |
PE20142325A1 (es) | Composiciones derivadas de la quitosana | |
AR128245A1 (es) | Nuevos derivados de ácido hialurónico como rellenos innovadores | |
BR112022016744A2 (pt) | Métodos para reduzir a degradação de polissorbato em formulações de fármaco | |
WO2015017340A3 (en) | Low swell tissue adhesive and sealant formulations | |
CU20210061A7 (es) | Composición vacunal que comprende el dominio alfa 3 de mica/b para el tratamiento del cáncer | |
Park et al. | Extracellular Matrix‐Bioinspired Anisotropic Topographical Cues of Electrospun Nanofibers: A Strategy of Wound Healing through Macrophage Polarization | |
CO2023017328A2 (es) | Polisacárido reticulado con fibroína y usos del material obtenido | |
MX2019003206A (es) | Gel de acido hialuronico con un cation de zinc divalente. | |
BR112022020809A2 (pt) | Composições e métodos para entrega terapêutica direcionada ao osso | |
EA201892239A1 (ru) | Материал на основе полимера, имеющий ковалентно связанные ферментативно деградируемые пептидные последовательности | |
AR076910A1 (es) | Un agente cosmetico de despigmentacion que comprende un carbohidrato de delta -tocoferilo |